News | December 22, 2021
World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
Sputnik M is a new member of the Sputnik vaccines family
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19
The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)